MINI SHORT - PFIZER INC | Market Closed - Deutsche Boerse AG 11:03:57 17/05/2024 pm IST | ||
| 4.17 EUR | +0.48% |
|
| Current month | -8.55% | ||
| 1 month | -8.75% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 17/24/17 | 4.17 | +0.48% |
| 16/24/16 | 4.15 | +0.24% |
| 15/24/15 | 4.14 | -1.90% |
| 14/24/14 | 4.22 | 0.00% |
| 13/24/13 | 4.22 | -0.94% |
Delayed Quote Deutsche Boerse AG
Last update May 17, 2024 at 11:03 pm IST
More quotesStatic data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | 
Citi
|
| WKN | KF6KYL |
| ISIN | DE000KF6KYL3 |
| Date issued | 22/12/2021 |
| Strike | 74.01 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.59 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.6 € |
|---|---|
| Lowest since issue | 1.65 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.64
USD
Average target price
31.94
USD
Spread / Average Target
+11.52%
- Stock Market
- Certificates
- Certificat
